How to buy Longboard Pharmaceuticals Stock

Longboard Pharmaceuticals, Inc. Common Stock is a biotechnology business based in the US. Longboard Pharmaceuticals IncCommon Stock shares (LBPH) are listed on the NASDAQ and all prices are listed in US Dollars. Longboard Pharmaceuticals IncCommon Stock employs 6 staff and has a market cap (total outstanding shares value) of 0.00.

Longboard Pharmaceuticals IncCommon Stock share price

Use our graph to track the performance of LBPH stocks over time.

Longboard Pharmaceuticals IncCommon Stock shares at a glance

• Key figures

Information last updated 2021-04-29.

52-week range	$9.50 - $17.60
50-day moving average	$14.18
200-day moving average	$14.18
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Longboard Pharmaceuticals IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Longboard Pharmaceuticals IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Longboard Pharmaceuticals, Inc. Common Stock by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Longboard Pharmaceuticals IncCommon Stock financials

Gross profit TTM	$0
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market capitalisation	$160.7 million

TTM: trailing 12 months

Shorting Longboard Pharmaceuticals IncCommon Stock shares

There are currently 3,009 Longboard Pharmaceuticals IncCommon Stock shares held short by investors – that's known as Longboard Pharmaceuticals IncCommon Stock's "short interest". This figure is 97.6% down from 125,313 last month.

There are a few different ways that this level of interest in shorting Longboard Pharmaceuticals IncCommon Stock shares can be evaluated.

Longboard Pharmaceuticals IncCommon Stock's "short interest ratio" (SIR)

Longboard Pharmaceuticals IncCommon Stock's "short interest ratio" (SIR) is the quantity of Longboard Pharmaceuticals IncCommon Stock shares currently shorted divided by the average quantity of Longboard Pharmaceuticals IncCommon Stock shares traded daily (recently around 50150). Longboard Pharmaceuticals IncCommon Stock's SIR currently stands at 0.06. In other words for every 100,000 Longboard Pharmaceuticals IncCommon Stock shares traded daily on the market, roughly 60 shares are currently held short.

To gain some more context, you can compare Longboard Pharmaceuticals IncCommon Stock's short interest ratio against those of similar companies.

• Biogen (BIIB.US): 2.98
• GlaxoSmithKline (GSK.US): 4.96
• Pfizer (PFE.US): 2.26

However Longboard Pharmaceuticals IncCommon Stock's short interest can also be evaluated against the total number of Longboard Pharmaceuticals IncCommon Stock shares, or, against the total number of tradable Longboard Pharmaceuticals IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Longboard Pharmaceuticals IncCommon Stock's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Longboard Pharmaceuticals IncCommon Stock shares in existence, roughly 0 shares are currently held short) or 0.0003% of the tradable shares (for every 100,000 tradable Longboard Pharmaceuticals IncCommon Stock shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Longboard Pharmaceuticals IncCommon Stock.

Find out more about how you can short Longboard Pharmaceuticals IncCommon Stock stock.

Longboard Pharmaceuticals IncCommon Stock share dividends

We're not expecting Longboard Pharmaceuticals IncCommon Stock to pay a dividend over the next 12 months.

You may also wish to consider:

• GlaxoSmithKline (GSK.US) (2.11% forward annual dividend yield)
• Pfizer (PFE.US) (3.9% forward annual dividend yield)

Longboard Pharmaceuticals IncCommon Stock overview

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020.

Frequently asked questions

• What percentage of Longboard Pharmaceuticals IncCommon Stock is owned by insiders or institutions?

  Currently 32.564% of Longboard Pharmaceuticals IncCommon Stock shares are held by insiders and 57.582% by institutions.

• How many people work for Longboard Pharmaceuticals IncCommon Stock?

  Latest data suggests 6 work at Longboard Pharmaceuticals IncCommon Stock.

• When does the fiscal year end for Longboard Pharmaceuticals IncCommon Stock?

  Longboard Pharmaceuticals IncCommon Stock's fiscal year ends in December.

• Where is Longboard Pharmaceuticals IncCommon Stock based?

  Longboard Pharmaceuticals IncCommon Stock's address is: 6154 Nancy Ridge Drive, San Diego, CA, United States, 92121